Whole Transcriptome Atlas Service Based in NanoString’s
Premier Access Sites to Offer the Cancer Transcriptome Atlas Service from Labs Across the Globe
The GeoMx Premier Access Site (GPAS) partners will enable a broader user base to try the Cancer Transcriptome Atlas (CTA) and evaluate the applicability of GeoMx DSP in their research. Eight global sites have been selected and include
“We are excited to be selected to join the GeoMx Premier Access Sites,” said Dr.
Expanding on the 1,800+-plex CTA, the GeoMx Whole Transcriptome Atlas (WTA) provides an unbiased view of 18,000+ protein-coding genes. The WTA unlocks new pathways to be explored by researchers and broadens GeoMx RNA profiling from oncology and immunology to include neuroscience, developmental biology, and other diverse fields. WTA utilizes the same workflow and chemistry as CTA, providing robust, sensitive performance on FFPE or Fresh Frozen samples.
“We’re experiencing a groundswell of interest from researchers that would like to leverage the power of next generation sequencing to study spatial biology,” said
The human WTA is now available through the TAP service. Under the program, a TAP customer can submit tissue samples to
Researchers interested in participating in NanoString’s Technology Access Program should contact us at TAP@nanostring.com.
The GeoMx DSP capabilities that are unlocked through use of NGS readout will be featured in an exclusive event, Advancing Science: A
To learn more about NanoString’s GeoMx Digital Spatial Profiler, please visit https://www.nanostring.com/products/geomx-digital-spatial-profiler/geomx-dsp.
For more information, please visit www.nanostring.com.
Vice President, Investor Relations & Corporate Communications